| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2117263 | Cancer/Radiothérapie | 2015 | 5 Pages |
Abstract
Stereotactic body radiation therapy is the standard treatment for inoperable patients with early-stage lung cancer. Local control rates range from 80Â to 90Â % 2Â years after treatment. The role of positron emission tomography in patient selection is well known, but its use for target definition or therapeutic response evaluation is less clear. We reviewed the literature in order to assess the current state of knowledge in this area.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
J.-E. Bibault, A. Oudoux, J. Durand-Labrunie, X. Mirabel, Ã. Lartigau, H. Kolesnikov-Gauthier,